|
MALMÖ, Sweden, July 18, 2019 /PRNewswire/ -- Imlifidase benefits highlighted in recent ATC presentations. Expansion outside transplantation with initiation of study in Guillain-Barré Syndrome (GBS) continues. Highlights for the second quarter 2019 - At the 2019 American Transplant... |
